Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RAD51 testing in patients with early HER2-negative breast cancer and homologous recombination deficiency: post-hoc analysis of the GeparOla trial.
Villacampa G, Llop-Guevara A, Filmann N, Herencia A, Fasching PA, Karn T, Marmé F, Klare P, Müller V, Stefek A, Schem C, Uleer C, Fehm T, Doering G, Stickeler E, van Mackelenbergh M, Felder B, Nekljudova V, Balmaña J, Denkert C, Loibl S, Serra V. Villacampa G, et al. Among authors: muller v. Clin Cancer Res. 2024 Dec 30. doi: 10.1158/1078-0432.CCR-24-3148. Online ahead of print. Clin Cancer Res. 2024. PMID: 39786436
How measurement noise limits the accuracy of brain-behaviour predictions.
Gell M, Eickhoff SB, Omidvarnia A, Küppers V, Patil KR, Satterthwaite TD, Müller VI, Langner R. Gell M, et al. Among authors: muller vi. Nat Commun. 2024 Dec 12;15(1):10678. doi: 10.1038/s41467-024-54022-6. Nat Commun. 2024. PMID: 39668158 Free PMC article.
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.
Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, Kurzeder C, Higgins MJ, Connolly RM, Baron-Hay S, Gión M, Guarneri V, Bianchini G, Wildiers H, Escrivá-de-Romaní S, Prahladan M, Bridge H, Kuptsova-Clarkson N, Scotto N, Verma S, Lin NU; DESTINY-Breast12 study group. Harbeck N, et al. Among authors: muller v. Nat Med. 2024 Dec;30(12):3780. doi: 10.1038/s41591-024-03349-0. Nat Med. 2024. PMID: 39653780 Free PMC article. No abstract available.
Advanced aspects of acetogens.
Poehlein A, Zeldes B, Flaiz M, Böer T, Lüschen A, Höfele F, Baur KS, Molitor B, Kröly C, Wang M, Zhang Q, Fan Y, Chao W, Daniel R, Li F, Basen M, Müller V, Angenent LT, Sousa DZ, Bengelsdorf FR. Poehlein A, et al. Among authors: muller v. Bioresour Technol. 2024 Dec 1:131913. doi: 10.1016/j.biortech.2024.131913. Online ahead of print. Bioresour Technol. 2024. PMID: 39626805 Free article. Review.
1,643 results